The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Cell-cycle checkpoints and cancer
Abstract
All life on earth must cope with constant exposure to DNA-damaging agents such as the Sun's radiation. Highly conserved DNA-repair and cell-cycle checkpoint pathways allow cells to deal with both endogenous and exogenous sources of DNA damage. How much an individual is exposed to these agents and how their cells respond to DNA damage are critical determinants of whether that individual will develop cancer. These cellular responses are also important for determining toxicities and responses to current cancer therapies, most of which target the DNA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CHK1 prevents new origin firing by inhibiting CDK2 through CDC25A degradation, thus hindering the subsequent loading of CDC45 on chromatin to form the pre-initiation complex [34].”
From The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia (2017) · cites this paper as [34]
In the citing paper
“The importance of the DNA damage checkpoint in the maintenance of genomic stability is underlined by the existence of many syndromes linked to mutations in checkpoint genes, causing increased cancer proneness or other clinical symptoms, especially neurological defects [13,14]”
From Mind the gap: keeping UV lesions in check (2011) · cites this paper as [13]
In the citing paper
“while p53-mutant mice are cancer prone, we noted that their predilection for mesenchymal and lymphoid malignancies, rather than epithelial cancers, did not represent the tumor types most commonly possessing p53 mutations in humans (101,102).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [101]
In the citing paper
“factors involved in DNA repair and DDR pathways have become therapeutic targets and are currently being tested in both laboratory and clinical studies [151, 222]”
From Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress (2014) · cites this paper as [222]
Citations
Cites
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Doll, R., & Peto, R. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1192 · Cited by 3,927
The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today
Peto, R. (1983) · Springer eBooks · doi:10.1007/978-1-4757-1117-2_30 · Cited by 3,504
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Self-citationCheckpoints: Controls That Ensure the Order of Cell Cycle Events
Hartwell, L. H., & Weinert, T. A. (1989) · Science · doi:10.1126/science.2683079 · Cited by 3,053
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Megabase Chromatin Domains Involved in DNA Double-Strand Breaks in Vivo
Rogakou, E. P., Boon, C., Redon, C., & Bonner, W. M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.905 · Cited by 2,422
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
Flagged first, then by citations
Research works printed but not linked: 1
- Ford, J. M. Clinical Oncology (eds Abeloff, M. et al.) Ch. 11, 191–205 (Elsevier, Philadelphia, 2004).
Cited by
Sorted by citations
Items 901–1,000 of 1,008
Wu, J., Lai, G., Wan, F., Xiao, Z., Zeng, L., Wang, X., Ye, F., & Lei, T. (2012) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.226.267 · Cited by 41
Zhang, X.-H., Cheng, Y., Shin, J.-Y., Kim, J.-O., Oh, J., & Kang, J. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.24592 · Cited by 41
The molecular mechanisms of vitamin C on cell cycle regulation in B16F10 murine melanoma
Hahm, E., Jin, D., Kang, J. S., Kim, Y., Hong, S., Lee, S. K., Kim, H., Jung, D. J., Kim, J. E., Shin, D. H., et al. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21336 · Cited by 42
Radioprotection by Hymenialdisine-Derived Checkpoint Kinase 2 Inhibitors
Nguyen, T. N., Saleem, R. S. Z., Luderer, M. J., Hovde, S., Henry, R. W., & Tepe, J. J. (2011) · ACS Chemical Biology · doi:10.1021/cb200320c · Cited by 41
di Rorà, A. G. L., Iacobucci, I., Imbrogno, E., Papayannidis, C., Derenzini, E., Ferrari, A., Guadagnuolo, V., Robustelli, V., Parisi, S., Sartor, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10535 · Cited by 41
Histone Deacetylase Inhibitors and Rational Combination Therapies
Grant, S., & Dai, Y. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-394387-3.00006-9 · Cited by 42
Qin, J.-L., Qin, Q., Wei, Z., Yu, Y.-C., Meng, T., Wu, C., Liang, Y., Liang, H., & Chen, Z. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.054 · Cited by 41
Teng, Y., Zhu, K., Xiong, C., & Huang, J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b00584 · Cited by 41
Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency
Araki, R., Hoki, Y., Suga, T., Obara, C., Sunayama, M., Imadome, K., Fujita, M., Kamimura, S., Nakamura, M., Wakayama, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13830-x · Cited by 42
Karaayvaz, M., Silberman, R. E., Langenbucher, A., Saladi, S. V., Ross, K. N., Zarcaro, E., Desmond, A. J., Yıldırım, M., Vivekanandan, V., Ravichandran, H., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay2611 · Cited by 42
PRR11 regulates late-S to G2/M phase progression and induces premature chromatin condensation (PCC)
Zhang, C., Zhang, Y., Li, Y., Zhu, H., Wang, S., Cai, W. L., Zhu, J., Ozaki, T., & Bu, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.139 · Cited by 41
Fitzgerald, J., Moureau, S., Drogaris, P., O’Connell, E., Abshiru, N. A., Verreault, A., Thibault, P., Grenon, M., & Lowndes, N. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014714 · Cited by 41
Pathway analysis using random forests with bivariate node-split for survival outcomes
Pang, H., Datta, D., & Zhao, H. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp640 · Cited by 41
AtmDeficiency Affects Both Apoptosis and Proliferation to Augment Myc-Induced Lymphomagenesis
Maclean, K. H., Kastan, M. B., & Cleveland, J. L. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0058 · Cited by 43
Self-citationTumor development: Haploinsufficiency and local network assembly
Smilenov, L. B. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.08.015 · Cited by 41
Semaan, J., Pinon, A., Rioux, B., Hassan, L., Limami, Y., Pouget, C., Fagnère, C., Sol, V., Diab‐Assaf, M., Simon, A., et al. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25600 · Cited by 41
Identification of novel, selective and potent Chk2 inhibitors
Larson, G., Yan, S., Chen, H., Rong, F., Hong, Z., & Wu, J. Z. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.067 · Cited by 41
Chromatin modulation and the DNA damage response
Costelloe, T., Fitzgerald, J., Murphy, N., Flaus, A., & Lowndes, N. F. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.06.031 · Cited by 41
Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation
Yan, Y., Hein, A. L., Etekpo, A., Burchett, K. M., Lin, C. H., Enke, C. A., Batra, S. K., Cowan, K. H., & Ouellette, M. M. (2014) · Oncotarget · doi:10.18632/oncotarget.2500 · Cited by 40
Chakraborty, S., Stark, J. M., Sun, C., Modi, H., Chen, W., O'Connor, T. R., Forman, S. J., Bhatia, S., & Bhatia, R. (2012) · Blood · doi:10.1182/blood-2011-05-352252 · Cited by 40
Determinants of Mitotic Catastrophe on Abrogation of the G2 DNA Damage Checkpoint by UCN-01
On, K. F., Chen, Y., Ma, H. T., Chow, J. P. H., & Poon, R. Y. C. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0809 · Cited by 42
Ramesh, R., Kuroda, S., Tam, J., Sokolov, K., & Roth, J. A. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s65990 · Cited by 40
Han, Y. H., Moon, H. J., You, B. R., Kim, S. Z., Kim, S. H., & Park, W. H. (2009) · Toxicology · doi:10.1016/j.tox.2009.10.001 · Cited by 40
RETRACTED: 2,3,7,8-Tetrachlorodibenzo-p-dioxin induced autophagy in a bovine kidney cell line
Fiorito, F., Ciarcia, R., Granato, G. E., Marfè, G., Iovane, V., Florio, S., Martino, L. D., & Pagnini, U. (2011) · Toxicology · doi:10.1016/j.tox.2011.10.004 · Cited by 40
RetractedHung, R. J., Baragatti, M., Thomas, D. C., McKay, J., Szeszenia‐Dąbrowska, N., Zaridze, D. G., Lissowska, J., Rudnai, P., Fabiánová, E., Mateș, D., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0494 · Cited by 40
Tumor-suppressing Function of Caspase-2 Requires Catalytic Site Cys-320 and Site Ser-139 in Mice
Ren, K., Lu, J., Porollo, A., & Du, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347625 · Cited by 40
Jiang, Y., Yu, K., Bao, J., Peng, W.-T., & Shao, Z. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0092 · Cited by 40
Zhang, W., Zhang, B., Zhang, W., Yang, T., Wang, N., Gao, C., Tan, C., Liu, H., & Jiang, Y. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.066 · Cited by 40
DNA Damage Repair System in Plants: A Worldwide Research Update
Giménez, E., & Manzano-Agugliaro, F. R. (2017) · Genes · doi:10.3390/genes8110299 · Cited by 40
Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells
Du, J., Shi, H.-R., Ren, F., Wang, J.-L., Wu, Q., Li, X., & Zhang, R. (2017) · BMC Cancer · doi:10.1186/s12885-017-3840-1 · Cited by 40
Zhou, J., Zhang, C.-J., Sui, X., Cao, S., Tang, F. R., Sun, S., Wang, S., & Chen, B. (2018) · Investigational New Drugs · doi:10.1007/s10637-017-0552-y · Cited by 40
The methyltransferase SETD6 regulates Mitotic progression through PLK1 methylation
Feldman, M., Vershinin, Z., Goliand, I., Elia, N., & Levy, D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804407116 · Cited by 40
Auslander, N., Wolf, Y. I., & Koonin, E. V. (2020) · Nature Communications · doi:10.1038/s41467-020-15094-2 · Cited by 41
Epigenetic based synthetic lethal strategies in human cancers
Gao, A., & Guo, M. (2020) · Biomarker Research · doi:10.1186/s40364-020-00224-1 · Cited by 40
Li, M., Yao, M., Wang, W., Wan, P., Chu, X., Zheng, Y., Yang, K., & Zhang, Y. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.11.019 · Cited by 40
Hegazy, M. F., Dawood, M., Mahmoud, N., Elbadawi, M., Sugimoto, Y., Klauck, S. M., Mohamed, N. S., & Efferth, T. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153409 · Cited by 40
IKKα Regulates Estrogen-induced Cell Cycle Progression by Modulating E2F1 Expression
Tu, Z., Prajapati, S., Park, K.-J., Kelly, N. J., Yamamoto, Y., & Gaynor, R. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512439200 · Cited by 40
Imidazole-4,5-dicarboxamide Derivatives with Antiproliferative Activity against HL-60 Cells
Perchellet, E. M., Perchellet, J., & Baures, P. W. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050160r · Cited by 40
Liao, M.-H., Lin, W., Wen, H.-C., & Pu, H. (2010) · Fitoterapia · doi:10.1016/j.fitote.2010.11.002 · Cited by 40
Nakada, S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25716e1 · Cited by 40
Nakada, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25716 · Cited by 40
Up-Regulation of Kin17 Is Essential for Proliferation of Breast Cancer
Zeng, T., Gao, H.-Y., Yu, P., He, H., Ouyang, X., Deng, L., & Zhang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025343 · Cited by 39
Regulation of tolerance to DNA alkylating damage by Dot1 and Rad53 in Saccharomyces cerevisiae
Conde, F., Ontoso, D., Acosta, I., Gallego-Sánchez, A., Bueno, A., & San-Segundo, P. A. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.07.003 · Cited by 40
Takashima, S., Saito, H., Takahashi, N., Imai, K., Kudo, S., Atari, M., Saito, Y., Motoyama, S., & Minamiya, Y. (2013) · Tumor Biology · doi:10.1007/s13277-013-1556-7 · Cited by 39
Screening of Hub Genes and Pathways in Colorectal Cancer with Microarray Technology
Wang, Y., & Zheng, T. (2014) · Pathology & Oncology Research · doi:10.1007/s12253-013-9739-5 · Cited by 39
Ma, X., Han, Y., Song, X., Do, T., Yang, Z., Ni, J., & Xie, T. (2016) · Development · doi:10.1242/dev.141069 · Cited by 39
Tessmann, J. W., Buss, J. H., Begnini, K. R., Berneira, L. M., Paula, F. R., de Pereira, C. M. P., Collares, T. V., & Seixas, F. K. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.060 · Cited by 39
Inherited Genetic Mutations and Polymorphisms in Malignant Mesothelioma: A Comprehensive Review
Panou, V., & Røe, O. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124327 · Cited by 40
Structure-activity relationships of Wee1 inhibitors: A review
Du, X., Li, J., Luo, X., Li, R., Li, F., Zhang, Y., Shi, J., & He, J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112524 · Cited by 39
Signaling pathways involved in cell cycle arrest during the DNA breaks
Sadoughi, F., Hallajzadeh, J., Asemi, Z., Mansournia, M. A., Alemi, F., & Yousefi, B. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103047 · Cited by 40
DDX39B contributes to the proliferation of colorectal cancer through direct binding to CDK6/CCND1
Zhang, H., He, C., Guo, X., Fang, Y., Lai, Q., Wang, X., Pan, X., Li, H., Qin, K., Li, A., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00827-7 · Cited by 39
DNA damage and cellular differentiation: More questions than responses
Simonatto, M., Latella, L., & Puri, P. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21275 · Cited by 39
Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia
Koorstra, J.-B. M., Hong, S., Shi, C., Meeker, A. K., Ryu, J. K., Offerhaus, G. J. A., Goggins, M., Hruban, R. H., & Maitra, A. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.114 · Cited by 39
Bennett, L. N., & Clarke, P. R. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.06.071 · Cited by 39
p53 control of bone remodeling
Liu, H., & Li, B. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22749 · Cited by 39
STAT1 activation in squamous cell cancer of the oral cavity
Laimer, K., Spizzo, G., Obrist, P., Gastl, G. A., Brunhuber, T., Schäfer, G., Norer, B., Rasse, M., Haffner, M. C., & Doppler, W. (2007) · Cancer · doi:10.1002/cncr.22813 · Cited by 40
Zhang, Y., Qian, D., Li, Z., Huang, Y., Wu, Q., Ru, G., Chen, M., & Wang, B. (2016) · Cell Stress and Chaperones · doi:10.1007/s12192-016-0693-5 · Cited by 39
Jiang, J., Matranga, C. B., Cai, D. D., Latham, V. M., Zhang, X., Lowell, A. M., Martelli, F., & Shapiro, G. I. (2003) · PubMed · Cited by 39
Iwamoto, K., Tashima, Y., Hamada, H., Eguchi, Y., & Okamoto, M. (2008) · Biosystems · doi:10.1016/j.biosystems.2008.05.016 · Cited by 39
Rowe, B. P., & Glazer, P. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2566 · Cited by 39
Rimmelé, P., Komatsu, J., Hupé, P., Roulin, C., Barillot, E., Dutreix, M., Conseiller, E., Bensimon, A., Moreau-Gachelin, F., & Guillouf, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4691 · Cited by 38
Li, Z., Musich, P. R., Serrano, M. A., Dong, Z., & Zou, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028326 · Cited by 38
Seize the engine: Emerging cell cycle targets in breast cancer
Fuentes‐Antrás, J., Bedard, P. L., & Cescon, D. W. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1544 · Cited by 40
Zhang, B.-Y., Wang, Y., Gong, H. F., Zhao, H., Lv, X., Yuan, G.-H., & Han, S.-R. (2015) · Europe PMC (PubMed Central) · Cited by 38
Inhibition of checkpoint kinase 1 sensitizes lung cancer brain metastases to radiotherapy
Yang, H., Yoon, S. J., Jin, J., Choi, S. H., Seol, H. J., Lee, J.-I., Nam, D., & Yoo, H. Y. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.106 · Cited by 38
Zhang, H., Ji, Y., Chen, Q., Jiao, X., Hou, L., Zhu, X., & Zhang, Z. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1016437 · Cited by 38
DNA damage stress response in germ cells: role of c-Abl and clinical implications
Gonfloni, S. (2010) · Oncogene · doi:10.1038/onc.2010.410 · Cited by 39
Restoration of paclitaxel resistance by CDK1 intervention in drug-resistant ovarian cancer
Bae, T., Weon, K.-Y., Lee, J., Eum, K., Kim, S., & Choi, J. W. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv140 · Cited by 38
Yu, P., Zhang, C., Gao, C., Ma, T., Zhang, H., Zhou, M., Yang, Y.-W., Yang, L., & Kong, L. (2017) · Oncotarget · doi:10.18632/oncotarget.19299 · Cited by 38
Han, B., Pei, Z., Shi, L., Wang, Q., Li, C., Zhang, B., Su, X., Zhang, N., Zhou, L., Zhao, B., et al. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s254969 · Cited by 38
Xu, F., Xi, H., Liao, M., Zhang, Y., Ma, H., Wu, M., Xue, Q., Sun, H., Zhang, Y., & Xia, Y. (2022) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04386-z · Cited by 38
The role of ATM and 53BP1 as predictive markers in cervical cancer
Roossink, F., Wieringa, H. W., Noordhuis, M. G., ten Hoor, K. A., Kok, M., Slagter‐Menkema, L., Hollema, H., de Bock, G. H., Pras, E., de Vries, E. G. E., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27488 · Cited by 38
SMARCAL1 and replication stress
Bansbach, C. E., Boerkoel, C. F., & Cortez, D. (2010) · Nucleus · doi:10.4161/nucl.1.3.11739 · Cited by 38
Mitotic catastrophe induced in HeLa cells by photodynamic treatment with Zn(II)-phthalocyanine
Acedo, P., Villanueva, Á., Cañete, M., Stockert, J., & Rello‐Varona, S. (1992) · International Journal of Oncology · doi:10.3892/ijo.32.6.1189 · Cited by 39
Das, D. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i42.7374 · Cited by 38
Increased expression of p21WAF1/CIP1 in kidney proximal tubules mediates fibrosis
Megyesi, J. K., Tarcsafalvi, A., Li, S., Hodeify, R. F., Seng, N. S. H. L., Portilla, D., & Price, P. M. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00489.2014 · Cited by 39
Chang-Dong, W. A. N. G., Huang, J., Gao, X., Li, Y., Zhou, S., Xu, Y. L., An, Z. O. U., Chang, J., Wang, Y., Yang, G., et al. (2010) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.90490 · Cited by 38
Schepeler, T., Lamy, P., Hvidberg, V., Laurberg, J. R., Fristrup, N., Reinert, T., Bártková, J., Tropia, L., Bártek, J., Halazonetis, T. D., et al. (2012) · Oncogene · doi:10.1038/onc.2012.381 · Cited by 39
Rodrı́guez, R., Gagou, M. E., & Meuth, M. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.4 · Cited by 38
Liu, W., Jiang, F., Bi, X., & Zhang, Y. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds307 · Cited by 38
Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside
Sriramulu, S., Thoidingjam, S., Brown, S. L., Siddiqui, F., Movsas, B., & Nyati, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114126 · Cited by 39
Wang, Y., Wang, C., Liu, T., Qi, H., Chen, S., Cai, X., Zhang, M., Aliper, A., Ren, F., Ding, X., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01476 · Cited by 39
Bouças, J., Fritz, C., Schmitt, A., Riabinska, A., Thelen, L., Peifer, M., Leeser, U., Nüernberg, P., Altmueller, J., Gaestel, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125745 · Cited by 37
Zhao, L., Miao, H., Li, W., Sun, Y., Huang, S., Li, Z., & Guo, Q. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22321 · Cited by 37
ATR and Rad17 collaborate in modulating Rad9 localisation at sites of DNA damage
Medhurst, A. L., Warmerdam, D. O., Akerman, İ., Verwayen, E. H., Kanaar, R., Smits, V. A. J., & Lakin, N. D. (2008) · Journal of Cell Science · doi:10.1242/jcs.033688 · Cited by 39
Tsang, L. W. K., Hu, N., & Underhill, D. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014447 · Cited by 39
Moretti, L., Niermann, K. J., Schleicher, S. M., Giacalone, N. J., Varki, V., Kim, K. W., Kopsombut, P., Jung, D. K., & Lü, B. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.01.060 · Cited by 37
Lin, H., Gong, J., Su, R. J., Chen, M., Song, L., Shen, C., Wang, F., Ma, Y., Zhao, H.-L., Yu, J., et al. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a0514-240r · Cited by 37
Preferential killing of p53-deficient cancer cells by reversine
Jèmaà, M., Galluzzi, L., Kepp, O., Boilève, A., Lissa, D., Senovilla, L., Harper, F., Pierron, G., Berardinelli, F., Antoccia, A., et al. (2012) · Cell Cycle · doi:10.4161/cc.20621 · Cited by 38
Methanol extract of the ethnopharmaceutical remedy Smilax spinosa exhibits anti-neoplastic activity
Seelinger, M., Popescu, R., Giessrigl, B., Jarukamjorn, K., Unger, C., Wallnöfer, B., Fritzer‐Szekeres, M., Szekeres, T., Díaz, R. E., Jäger, W. R., et al. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1538 · Cited by 37
SCAI promotes DNA double-strand break repair in distinct chromosomal contexts
Hansen, R. K., Mund, A., Poulsen, S. L., Sandoval, M., Klement, K., Tsouroula, K., Tollenaere, M. A. X., Räschle, M., Soria, R., Offermanns, S., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3436 · Cited by 37
Guo, Z., Wang, F., Yang, D., Yao, L., Yu, X., Fu, D., Li, J., & Jin, C. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s166769 · Cited by 37
Byun, W. S., Jin, M., Yu, J., Kim, W. K., Song, J., Chung, H., Jeong, L. S., & Lee, S. K. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.10.002 · Cited by 37
The Role of p38γ in Cancer: From review to outlook
Xu, W., Liu, R., Dai, Y., Hong, S., Dong, H., & Wang, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.63537 · Cited by 37
Cell Cycle as a Target of Antineoplastic Drugs
Falco, M. D., & Luca, A. D. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791033914 · Cited by 37
A Novel ATM/TP53/p21-Mediated Checkpoint Only Activated by Chronic γ-Irradiation
Cao, L., Kawai, H., Sasatani, M., Iizuka, D., Masuda, Y., Inaba, T., Suzuki, K., Ootsuyama, A., Umata, T., Kamiya, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104279 · Cited by 37
Lin, Z. P., Belcourt, M. F., Carbone, R., Eaton, J. S., Penketh, P. G., Shadel, G. S., Cory, J. G., & Sartorelli, A. C. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.11.014 · Cited by 38
Nuclear Chk1 prevents premature mitotic entry
Matsuyama, M., Goto, H., Kasahara, K., Kawakami, Y., Nakanishi, M., Kiyono, T., Goshima, N., & Inagaki, M. (2011) · Journal of Cell Science · doi:10.1242/jcs.086488 · Cited by 38
E2F4 Function in G2 Maintaining G2-arrest to Prevent Mitotic Entry with Damaged DNA
Plesca, D. C., Crosby, M. E., Gupta, D., & Almasan, A. (2007) · Cell Cycle · doi:10.4161/cc.6.10.4259 · Cited by 37
Şahin, İ. H., Iacobuzio–Donahue, C. A., & O'Reilly, E. M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1094057 · Cited by 39
Metadata
- Authors
- Kastan, M. B., & Bartek, J.
- Affiliations
- St. Jude Children's Research Hospital (US)
- ORCID
- Kastan, Michael B.
- Venue
- Nature
- Published
- 2004-11
- Volume
- 432
- Issue
- 7015
- Pages
- 316-323
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1965239527
- Cited by
- 2,836
- References
- 98
- Citations by year
- 2026: 61 · 2025: 71 · 2024: 70 · 2023: 111 · 2022: 132 · 2021: 151 · 2020: 144 · 2019: 119 · 2018: 114 · 2017: 130 · 2016: 141 · 2015: 138 · 2014: 151 · 2013: 141 · 2012: 164
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- cell cycle checkpoints, DNA damage response, DNA repair, cancer, DNA-damaging agents, radiation, cancer therapy toxicity, carcinogenesis
- MeSH terms
- Animals, Cell Cycle, DNA Damage, Humans, Neoplasms, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review